Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

Brief summary (registry, in English)

This phase III trial studies how well combination chemotherapy and surgery work in treating young patients with Wilms tumor. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving combination chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. Giving it after surgery may kill any tumor cells that remain after surgery.

What you commit to

• Study type: Interventional · Phase 3
• Participants enrolled: 249
• From 24 Aug 2009 to the primary completion date, 31 Dec 2016
• 169 sites in 6 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: - to 29 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (169)

Sites in registry order. Pick your city on the disease page to sort them by distance.